Reynaldo Garcia from the UNC Lineberger Comprehensive Cancer Center Explains the BCR-ABL Study
OncLive TV
Reynaldo Garcia from the University of North Carolina Lineberger Comprehensive Cancer Center on BCR-ABL Testing in Chronic Myelogenous Leukemia
Advertisement
Donna Berry from the Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the Future of Oncology Nursing
Donna Berry from the Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the Implications of Oral Oncolytics
Kristie Howlett from the Sutter Roseville Medical Center on the Importance of Patient Hand Wiping
Donna Berry from Phyllis F. Cantor Center at the Dana-Farber Cancer Institute on the Symptom Management Excellence Initiative
Advertisement
Janet Hampton from the University of Michigan Health System Cancer Center Explains the Distress Thermometer Study
Janet Hampton University of Michigan Health System Cancer Center Explains Distress Thermometer Study Results
Donna Berry Discusses Her Prostate Cancer Research
Juanita Madison from the Seattle Cancer Care Alliance on Handling the Provenge Treatment Process
Janet Hampton Describes the Distress Thermometer
Juanita Madison from Seattle Cancer Care Alliance Describes the Provenge Treatment Process
Suzanne Beauchene from Seattle Cancer Care Alliance Discusses the Provenge Treatment Process from Start to Finish
Dr. Markman on HPV Testing to Detect Cervical Cancer
Dr. Pecora on HPV Cervical Cancer Findings
Dr. Markman Discusses the Swedish PSA Screening
Dr. Pecora on the Breast Cancer Prevention Trial
Dr. Pecora on Results from the Swedish PSA Study
Dr. Markman Discusses the Olaparib Phase II Trial
Dr. Pecora on Ovarian Cancer PARP Inhibitor for Ovarian Cancer
Dr. Markman Discusses the Importance of Cancer Screening
Dr. Pecora Evaluates the Prostate, Lung, Colorectal and Ovarian Cancer Study Findings
Dr. Markman on Taxane-Induced Neuropathy Biomarkers
Dr. Pecora Talks About Taxane-Induced Neuropathy Study
Dr. Pecora on the Pathway Inhibitor Cabozantinib (XL184)
Susan Moore on the Importance of Oral Oncolytic Patient Education
Susan Moore Explains Nonadherence to Oral Oncolytics
Jane Armer director of ALFP Discusses Lymphedema Symptoms and Treatments
Jane Armer the director of ALFP on Findings From Her Lymphedema Research
Susan Moore on Effects of Nonadherence to Oral Oncolytics
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5